Matches in Nanopublications for { ?s ?p "DDI between Propafenone and Mirabegron - Mirabegron is a moderate CYP2D6 inhibitor and may cause an increase in exposure of CYP2D6 substrates. Monitor concomitant therapy closely. [drugbank_resource:DB01182_DB08893]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.